Edenred Shares Drop 2.27% to €21.57 After Rebound, Shorts at 9.59%
Edenred shares fall 2.27% to €21.57 by midday, among the largest declines in the SBF 120. The movement follows a 4% rebound the previous day, which had allowed the stock to break through its resistance at €21.76. The consolidation occurs in an otherwise positive Parisian market, with the SBF 120 up 0.56% during the session.
Consolidation After Breaking Resistance the Previous Day
The stock falls back below the €21.76 threshold, a level crossed during a significant rise the previous day. The RSI at 69 indicates the exhaustion of the rebound that began in late April, nearing the overbought zone. Edenred is the second largest decline in the SBF 120 at mid-session, behind Nanobiotix, which fell by 7.22%. Despite this setback, the stock maintains a three-month gain of 21.11% and remains above its three moving averages. The price is 11.07% above the MM50 (€19.42) and 6% above the MM200 (€20.35), confirming the medium-term momentum. However, the performance over one year remains negative at -20.79%.
Persistent Selling Pressure and Discounted Valuation Relative to the Sector
According to reviewed statements, the cumulative net short positions reach 9.59% of the capital, supported by ten funds including Canada Pension Plan Investment Board (1.81%), Two Sigma Investments (1.39%), and Marshall Wace (1.22%). The level has decreased by 1.01 points over 30 days but remains high, indicating persistent selling pressure on the stock. The next important date on the financial calendar is the publication of the first half of 2026's revenue, expected on July 23, 2026.
